Navigation Links
AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy

is Conference, Denver, Colorado, November 2-5, 2006, indicated that dosing of Moli1901 for 5 consecutive days by the inhalation route improved lung function in a dose-dependent manner.

About AOP Orphan

AOP Orphan Pharmaceuticals AG is a privately held corporation founded in Vienna in 1997. The company is dedicated to developing, marketing and distributing medicines in niche indications on a Pan-European level with special focus on Central and Eastern Europe, Middle East and Southern Asia.

About Lantibio

Lantibio, Inc. is a development pharmaceutical company focused on discovery, development, and marketing of products for the treatment of ocular disease and serious respiratory conditions. Lantibio's lead product, Moli1901 holds an IND in CF in the US as well as Orphan Drug status in that indication.

This press release might contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from AOP Orphan's and/or Lantibio's expectations and projections. Risks and uncertainties include success of clinical trials for AOP Orphan's and/or Lantibio's products, intellectual property risks, need for additional financing or capital, ability to develop and successfully commercialize our products, ability to enter into licensing agreements, and the ability of the competition to render AOP Orphan's and/or Lantibio's product candidates or technologies obsolete or noncompetitive. AOP Orphan and Lantibio assume no obligation to update any forward-looking statements as a result of new information or future events or developments, except as required by law.

CONTACT: Rudolf S. Widmann, CEO of AOP Orphan Pharmaceuticals, +43 1 50372 44, or ; Luis Molina, President-CEO ofLantibio, +1-919-960-0217, or ; Copy Editing
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
2. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
3. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

Post Your Comments:
(Date:11/20/2009)...TH MEETING, Pa., Nov. 20 /PRNewswire-USNewswire/ -... that questions why currently available medication...eing ignored, ECRI Institute, an independent nonpr...idence on Finasteride for Prevention of Prostate ..., 2009, New York Times article, " Drugs to Deter...
(Date:11/20/2009)...ON, N.J., Nov. 20 Solige... the Company), formerly known as DOR BioPharma, In...today that it has formed a consortium to develop t...her rapidly acting vaccines. Soligenix received a ...Allergy and Infectious Diseases (NIAID), a divisio...
(Date:11/19/2009)...nce, Nov. 19 In response to an eve...s and illegal medicines, Operation Pangea II, invo...d the World Health Organization,s International Me...CT) to highlight the dangers of buying medicines o...ted in a series of arrests and the seizure of thou...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Researchers Detect Blood Clotting Mechanism 47989 1Researchers Detect Blood Clotting Mechanism 47989 2Body and Weight Checking May Signify an Eating Disorder 47985 1Body and Weight Checking May Signify an Eating Disorder 47985 2Body and Weight Checking May Signify an Eating Disorder 47985 3NYC Benefit Raises 241 4m for the Damon Runyon Cancer Research Foundation Honors Merck 47981 1NYC Benefit Raises 241 4m for the Damon Runyon Cancer Research Foundation Honors Merck 47981 2NYC Benefit Raises 241 4m for the Damon Runyon Cancer Research Foundation Honors Merck 47981 3
...Oquin Instillation Immediately Following Transuret...er Cancer Study, IRVINE, Calif., April 19, 2007 /P...Inc., today announced results of a Phase,2b study ...presentation of preclinical data of SPI (IRL)-1620...ican Association of Cancer,Research, held at the L...
...INGTON, Mass.--(BUSINESS WIRE)--Apr 18, 2007 - Cri...unced that new,preclinical research demonstrating ...for High Mobility Group Box-1 protein (HMGB1), a,p...rotein, will be,published in the May 2007 issue of...hat HMGB1 is part of DNA complexes that,can stimul...
Other Medicine Technology:Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 2Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 3Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 4Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 5Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 6Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 7Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 8Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 2Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 3Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 4Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 5
(Date:11/22/2009)...1 Congressman Chaka Fat... United States Senate,s vote tonight to proceed to..., "Senators Arlen Specter and Bob Casey deserve t... for casting stand-up, critical votes in the Senat...ordable Health Care Reform legislation to full deb...
(Date:11/21/2009)... 21 DNC Chairman Tim Ka...e voted to begin full debate of health insurance r...om.com/cgi-bin/prnh/20080519/DNCLOGO ) ,, "To...road to enacting health insurance reform. By clear...w have an opportunity to debate the health reform ...
(Date:11/21/2009)...1 Milvia Lopez, by her attorney MI...filed suit, in Supreme Court, New York County, bea...at while Ms. Lopez underwent a routine transesopha...ITAL , doctors used an HIV infected scope exposing...veral hours after being discharged from the proced...
(Date:11/21/2009)...cusses Key Provisions of Legislation, Continues Pu...HARLES, Ill., Nov. 21 ...e landmark Affordable Health Care for America Act ...rm legislation forward, Congress has taken decisiv...tem. Today, AARP hosted an educational forum to d...
(Date:11/21/2009)... based medical credentialing software company Inte... a partnerhsip with Amerinet, Inc., the leading he... help to transform quality care within the healthc...ember 21, 2009 -- ISG Group, LLC, doing business a... with Amerinet Inc., a leading national healthcare...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2
...CSHL) have taken the search for cancer-causing gen... paper, they confirm that a gene called DLC1 is a ... mice that its deletion, inactivation or loss prec...ocellular carcinoma, or HCC). , The team,s succ...
... chairman & chief executive officer, Medco Health ...ress the Goldman Sachs Twenty-Ninth Annual,Global ...entation at the Ritz Carlton, Laguna Niguel, CA, w...e via a simulcast link and the,accompanying slides...
...atic and spinal cancer, SHERWOOD, Ore., June 3 , ... life at Avamere at,Sherwood in Oregon. The South ... frequent visits from his daughter Yolanda and two...es for,celebrities. In 1977, he finished Eyola, a ...
...,mounting to win the time, attention and interest ...d research shows that the most sought-after,clinic...nical trial,invitations that they receive at their...The toolkit recently released by Best Practices, L...
...Few of Dad,s Favorite Things Available at CVS/ph...KET, R.I., June 3 CVS/pharmacy, America,s,largest...ationwide, offers,shoppers a wide selection of aff...ear but they do not have,to sacrifice quality. Sho...
... Images of the inside of the intestine can be obta...t is no larger than a candy. It makes its way thro...stinal villi to an external receiver which the pat...amera is not very suitable for examinations of the...
Other Medicine News:Health News:CSHL scientists trace causal link between a tumor suppressor gene and liver cancer 2Health News:CSHL scientists trace causal link between a tumor suppressor gene and liver cancer 3Health News:Medco CEO to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference 2Health News:Sherwood, Oregon Sailor, 78, Goes on Final Voyage 2Health News:Best Practice Toolkit Supports Recruitment of Top Clinical Investigators 2Health News:Practical Gear and Personal Gadgets: CVS/pharmacy Offers a Wide Selection of Affordable Gifts to Delight Dad This Father's Day 2Health News:Practical Gear and Personal Gadgets: CVS/pharmacy Offers a Wide Selection of Affordable Gifts to Delight Dad This Father's Day 3Health News:Magnet-controlled camera in the body 2
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: